First Trust NYSE Arca Biotechnology Index Fund (FBT) Dividend Yield, History & Forecast

First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund (ETF) listed on the New York Stock Exchange Arca. The most recent ex-dividend date was December 13, 2024, with payment scheduled for December 31, 2024. market capitalization is approximately $1.73B.

Loading quote...

FBT fund composition

FBT holds 30 positions, with 37.6% of assets in its ten largest. It charges an expense ratio of 0.55%, and manages $3.08B.

Top 10 holdings

HoldingWeight
GMABGenmab A/S (ADR)4.89%
REGNRegeneron Pharmaceuticals, Inc.3.95%
HALOHalozyme Therapeutics, Inc.3.77%
EXELExelixis, Inc.3.68%
GILDGilead Sciences, Inc.3.59%
BIIBBiogen Inc.3.57%
AMGNAmgen Inc.3.57%
ALKSAlkermes Plc3.55%
TGTXTG Therapeutics, Inc.3.51%
VCYTVeracyte, Inc.3.51%

Sector allocation

Healthcare100.0%

Frequently Asked Questions about First Trust NYSE Arca Biotechnology Index Fund (FBT)

When does First Trust NYSE Arca Biotechnology Index Fund pay its next dividend?
The most recent ex-dividend date was December 13, 2024. The next scheduled dividend payment date is December 31, 2024.
Is First Trust NYSE Arca Biotechnology Index Fund a Dividend Aristocrat?
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is First Trust NYSE Arca Biotechnology Index Fund in?
First Trust NYSE Arca Biotechnology Index Fund (FBT) operates in the Financial Services sector, specifically the Asset Management industry.